Dendrimer transgene carrier modified with bone-targeting peptide and naphthalimide, preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 西安九清医疗科技有限公司
- Publication Date
- 2021-06-29
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of polymer chemistry and biomaterials, and in particular relates to a dendrimer transgene carrier modified with a bone-targeting peptide and naphthalimide, a preparation method and application thereof. Background technique
[0002] As a new type of treatment, gene therapy has shown great application potential in the treatment of major diseases such as cancer, AIDS, and osteoporosis. However, due to the lack of safe and efficient targeted gene carriers, there has been no breakthrough in gene therapy for bone diseases such as osteoporosis.
[0003] Gene therapy refers to the introduction of exogenous normal genes into target cells by means of gene carriers to correct or compensate diseases caused by gene defects or abnormalities, so as to achieve the purpose of treatment. However, naked DNA generally exists in the form of a stretched linear helix with a loose volume, and the DNA molecule itself is a negativel...